Therapeutic Angiogenesis
Showing 1 - 25 of >10,000
Coronary Artery Disease Trial in Houston (Stem Cell Therapy, Control (plasma))
Active, not recruiting
- Coronary Artery Disease
- Stem Cell Therapy
- Control (plasma)
-
Houston, TexasTexas Heart Institute/Baylor St. Luke's Medical Center
Apr 25, 2022
Peripheral Arterial Occlusive Disease, Critical Limb Ischemia Trial in Tainan, Taipei (RV-P1501)
Withdrawn
- Peripheral Arterial Occlusive Disease
- Critical Limb Ischemia
- RV-P1501
-
Tainan, Taiwan
- +1 more
Mar 1, 2022
Therapeutic Combination in Advanced or Metastatic Kidney Cancer
Not yet recruiting
- Renal Cell Carcinoma
- +2 more
- Blood collection
- Tumour samples
-
Paris, France
- +1 more
Mar 9, 2022
Melanoma, Malignant Melanoma, Stage IIIA Melanoma Trial in Orange (procedure, other, drug)
Completed
- Melanoma
- +4 more
- therapeutic conventional surgery
- +3 more
-
Orange, CaliforniaChao Family Comprehensive Cancer Center
Dec 30, 2020
Angiogenesis in Dermatologic Diseases: A Potential Therapeutic
Withdrawn
- Dermatologic Diseases
- skin tissue sample
-
Irvine, California
- +1 more
Apr 28, 2020
HIV-1 Infection Trial in Puerto Rico, United States (atorvastatin, for atorvastin)
Completed
- HIV-1 Infection
- atorvastatin
- placebo for atorvastin
-
Birmingham, Alabama
- +30 more
Jul 31, 2021
Peripheral Arterial Disease Trial in Louisville (Carnosine)
Not yet recruiting
- Peripheral Arterial Disease
- Carnosine
-
Louisville, KentuckyUniversity of Louisville
Nov 16, 2022
Ischemic Dilated Cardiomyopathy (IDCM) Trial in Canada, United States (ixmyelocel-T, Placebo)
Completed
- Ischemic Dilated Cardiomyopathy (IDCM)
- ixmyelocel-T
- Placebo
-
Birmingham, Alabama
- +35 more
May 25, 2021
Recovery in Post-stroke Rehabilitation
Completed
- Ischemic Stroke
-
Lodz, PolandMedical University of Lodz
Feb 20, 2023
Peripheral Arterial Disease Trial in Louisville (Carnosine, Placebo)
Completed
- Peripheral Arterial Disease
- Carnosine
- Placebo
-
Louisville, KentuckyUniversity of Louisville
Aug 3, 2022
Peripheral Arterial Disease Trial in Orange (VibratoSleeve Therapeutic Ultrasound Device)
Recruiting
- Peripheral Arterial Disease
- VibratoSleeve Therapeutic Ultrasound Device
-
Orange, CaliforniaVascular & Interventional Specialists of Orange County
May 24, 2023
Keloid Trial in Beijing (68Ga-FAPI, (68)Ga-RGD)
Recruiting
- Keloid
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Mar 2, 2022
Limb Ischemia, Diabetic Foot Trial in Spain (High dose allogeneic mesenchymal stromal cells, Low dose allogeneic mesenchymal
Recruiting
- Limb Ischemia
- Diabetic Foot
- High dose allogeneic mesenchymal stromal cells
- +2 more
-
Alicante, Spain
- +9 more
Jul 5, 2022
Critical Limb Ischemia, Peripheral Arterial Disease Trial in Kuala Lumpur (Stempeucel®)
Not yet recruiting
- Critical Limb Ischemia
- Peripheral Arterial Disease
- Stempeucel®
-
Kuala Lumpur, MalaysiaHospital Canselor Tunku Mukhriz
May 2, 2023
Critical Limb Ischemia, Buerger's Disease Trial in Kuala Lumpur (Adult human bone marrow derived, cultured, pooled, allogeneic
Not yet recruiting
- Critical Limb Ischemia
- Buerger's Disease
- Adult human bone marrow derived, cultured, pooled, allogeneic mesenchymal stromal cells
-
Kuala Lumpur, MalaysiaHospital Canselor Tunku Mukhriz
May 2, 2023
Malignant Brain Tumors Trial in Berkel en Rodenrijs (procedure, device, other)
Recruiting
- Malignant Brain Tumors
- intra-arterial injection
- +2 more
-
Berkel en Rodenrijs, Zuid Holland, NetherlandsLaurens Groenendijk
Apr 3, 2023
Solid Tumor, Adult Trial in Beijing (Vaccine)
Not yet recruiting
- Solid Tumor, Adult
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Aug 3, 2023
Type 1 Diabetic Nephropathy Trial in Cairo (oral sitagliptin supplementation)
Completed
- Type 1 Diabetic Nephropathy
- oral sitagliptin supplementation
-
Cairo, EgyptNancy Elbarbary
Nov 2, 2023
Purinergic Signaling and the Postmenopausal Heart
Recruiting
- Diastolic Heart Failure
- Heart Failure With Preserved Ejection Fraction
- Gender
-
Boston, MassachusettsBeth Israel Deaconess Medical Center
Aug 28, 2023
Lung Cancer, NSCLC Stage IV, Metastatic NSCLC - NSCLC Trial in Kansas City, Overland Park, Lee's Summit (Cabozantinib,
Not yet recruiting
- Lung Cancer
- +3 more
-
Kansas City, Kansas
- +3 more
May 12, 2023
Type 2 Diabetes Trial in Marseille (Liraglutide, Metformin or sulfonylurea)
Completed
- Type 2 Diabetes
- Liraglutide
- Metformin or sulfonylurea
-
Marseille, FranceNutrition department, pole ENDO - Assistance Publique Hôpitaux M
Jun 14, 2021
Hepatocellular Carcinoma Trial in Hangzhou (PVE+cTACE+Camrelizumab+Apatinib, cTACE+Atirizumab+Bevacizumab)
Recruiting
- Hepatocellular Carcinoma
- PVE+cTACE+Camrelizumab+Apatinib
- cTACE+Atirizumab+Bevacizumab
-
Hangzhou, Zhejiang, China2nd Affiliated Hospital, School of Medicine, Zhejiang University
Feb 26, 2023